Wentai Pharma
闻泰医药
Wentai Pharma
Biotech/Healthcare
Wentai Pharma develops therapies for chronic metabolic diseases. Drawing on its deep understanding of metabolic targets' mechanisms of action and GPCR protein structures, the company is developing differentiated or otherwise advantaged new drugs for weight loss.
Latest round: Series B (2024)
Source: ChinaBulls — chinabulls.com
Last updated 2024-10-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.